Related Experiment Video
Updated: May 12, 2026

Using Single Sensillum Recording to Detect Olfactory Neuron Responses of Bed Bugs to Semiochemicals
Published on: January 18, 2016
A novel prolixicin identified in common bed bugs with activity against both bacteria and parasites
Sanam Meraj1, Arshvir Singh Dhari2, Emerson Mohr2
1Department of Biological Sciences, Simon Fraser University, Burnaby, BC, V5A1S6, Canada. smeraj@sfu.ca.
Abstract:
The hematophagous common bed bug, Cimex lectularius, is not known to transmit human pathogens outside laboratory settings, having evolved various immune defense mechanisms including the expression of antimicrobial peptides (AMPs). We unveil three novel prolixicin AMPs in bed bugs, exhibiting strong homology to the prolixicin of kissing bugs, Rhodnius prolixus, and to diptericin/attacin AMPs. We demonstrate for the first time sex-specific and immune mode-specific upregulation of these prolixicins in immune organs, the midgut and rest of body, following injection and ingestion of Gr+ (Bacillus subtilis) and Gr- (Escherichia coli) bacteria. Synthetic CL-prolixicin2 significantly inhibited growth of E. coli strains and killed or impeded Trypanosoma cruzi, the Chagas disease agent. Our findings suggest that prolixicins are regulated by both IMD and Toll immune pathways, supporting cross-talk and blurred functional differentiation between major immune pathways. The efficacy of CL-prolixicin2 against T. cruzi underscores the potential of AMPs in Chagas disease management.
Insights
Bed bugs express novel antimicrobial peptides (AMPs) called prolixicins, which show sex-specific immune responses. These prolixicins effectively combat bacteria and the Chagas disease agent Trypanosoma cruzi.
Area of Science:
- Insect immunology
- Antimicrobial peptides
- Vector-borne diseases
Background:
- The common bed bug (Cimex lectularius) possesses immune defenses, including antimicrobial peptides (AMPs), despite not transmitting pathogens outside labs.
- AMPs are crucial for innate immunity in insects, defending against microbial infections.
Purpose of the Study:
- To identify and characterize novel AMPs in bed bugs.
- To investigate the regulation and function of these AMPs in response to bacterial challenge.
- To assess the potential of these AMPs against human pathogens, specifically Trypanosoma cruzi.
Main Methods:
- Identification and sequencing of novel prolixicin AMPs in Cimex lectularius.
- Analysis of AMP expression in response to Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) bacterial infections.
- In vitro assays to evaluate the antimicrobial activity of synthetic CL-prolixicin2 against E. coli and T. cruzi.
Main Results:
- Three novel prolixicin AMPs were identified in bed bugs, homologous to those in kissing bugs and other insect AMPs.
- Expression of these prolixicins was upregulated in a sex-specific and immune-response-specific manner in the midgut and body.
- Synthetic CL-prolixicin2 demonstrated significant inhibition of E. coli growth and efficacy against Trypanosoma cruzi.
Conclusions:
- Prolixicins represent a key component of bed bug innate immunity, regulated by both IMD and Toll pathways.
- The findings suggest cross-talk between major insect immune pathways.
- CL-prolixicin2's activity against T. cruzi highlights the potential of AMPs for managing Chagas disease.
Related Concept Videos
Cytoskeletal Proteins in Bacteria
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Microbial Interactions: Parasitism
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

